A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Hepatic Impairment

Clinical trial NCT04859426 · COMPLETED

Trial details

NCT number: NCT04859426
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2021-06-09
Primary completion: 2022-05-14
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.